The document discusses the Warburg effect, where cancer cells preferentially use glycolysis over oxidative phosphorylation to generate energy, even in the presence of oxygen. This allows cancer cells to rapidly proliferate by generating ATP and biomass through glycolysis. The effect occurs because cancer cells overexpress hypoxia-inducible factor 1, increasing glycolytic enzymes and decreasing mitochondrial function. While the exact cause is still unknown, the Warburg effect provides cancer cells a growth advantage and is exploited in PET scanning and as a target for potential anticancer drugs.